OncoMed Pharmaceuticals Lands $154,000,000 New Funding Round

  • Feed Type
  • Date
    11/4/2008
  • Company Name
    OncoMed Pharmaceuticals
  • Mailing Address
    800 Chesapeake Drive Redwood City, CA 94063
  • Company Description
    OncoMed Pharmaceuticals is discovering and developing monoclonal antibodies and small molecules capable of destroying “cancer stem cells”, a recently discovered type of cell believed to seed the growth of cancers and underlie cancer’s ability to spread and take root in tissues.
  • Website
    http://www.oncomed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $154,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    GlaxoSmithKline
  • Venture Investor
    Latterell Venture Partners
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    The Vertical Group
  • Venture Investor
    De Novo Ventures
  • Venture Investor
    Adams Street Partners
  • Venture Investor
    Bay Partners

Trending on Xconomy